Bepirovirsen

New Hepatitis B Drug Produces Functional Cure in About One in Five Patients

Regulators in the US, Europe, Japan and China are fast-tracking reviews after phase 3 results that could shorten or stop lifelong antiviral therapy for a subgroup of patients.